Cell Therapeutics, Inc. (CTIC) Narrows Q2 Loss
Tweet
Share
E-mailGet Alerts CTIC Hot Sheet
Price: $9.09 --0%
Financial Fact:
Net loss attributable to CTI: -29.18M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Net loss attributable to CTI: -29.18M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Cell Therapeutics, Inc. (NASDAQ: CTIC) reported Q2 EPS of ($0.14), versus ($0.48) reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Lument Finance Trust (LFT) Misses Q2 EPS by 17c
- Eton Pharmaceuticals Inc. (ETON) Tops Q2 EPS by 28c, Raises Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
